The journal PLOS Pathogens abruptly retracts the seminal paper linking XMRV to disease.
Advertisement
The Scientist
Most Recent
A seventh patient succumbs to a deadly, drug-resistant superbug terrorizing the National Institutes of Health Clinical Center.
Reinvestigating a natural antibiotic compound reveals its potential as a tuberculosis drug.
Many vaccines are on the market for various serogroups of meningococcal disease, but a solution to provide broad protection against MenB remains elusive.
Researchers identified the 3-step process leaf-cutter ants use to grow helpful bacteria on their bodies.
Friendly sinus bacteria may keep sinusitis-causing strains in check.
A cheap pain reliever that can kill drug-resistant, tuberculosis-causing bacteria may never be tested.
The United Kingdom government has devoted £10 million towards the goal of making all of the research it funds open access by next spring.
With a cardboard box, a light source, and some filters, roadside clinics can accurately test for tuberculosis.
Mimicking a host-cell histone protein offers flu a sneaky tactic to suppress immune response.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
